The hepatitis B epidemic and the urgent need for cure preparedness

More than 250 million people worldwide are chronically infected with the hepatitis B virus (HBV). In this Comment, members of the International Coalition to Eliminate HBV appraise the current policy environment and the need for appropriate cure research and preparedness to complement the WHO global elimination strategy, the HBV vaccine and the well-tolerated but poorly accessed therapy.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    Razavi-Shearer, D. et al. Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study. Lancet Gastroenterol. Hepatol. 3, 383–403 (2018).

    Article  Google Scholar 

  2. 2.

    World Health Organization. Global health sector strategy on viral hepatitis, 2016–2021. Towards ending viral hepatitis (WHO, 2016).

  3. 3.

    Papatheodoridis, G. V. et al. Risk of hepatocellular carcinoma in chronic hepatitis B: assessment and modification with current antiviral therapy. J. Hepatol. 62, 956–967 (2015).

    Article  PubMed  Google Scholar 

  4. 4.

    World Health Organization. Global hepatitis report 2017 (WHO, 2017).

  5. 5.

    Fattovich, G., Bortolotti, F. & Donato, F. Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors. J. Hepatol. 48, 335–352 (2008).

    Article  PubMed  CAS  Google Scholar 

  6. 6.

    United Nations. Transforming our world: the 2030 agenda for sustainable development. (UN General Assembly, 2015).

  7. 7.

    Stenberg, K. et al. Financing transformative health systems towards achievement of the health Sustainable Development Goals: a model for projected resource needs in 67 low-income and middle-income countries. Lancet Global Health 5, e875–e887 (2017).

    Article  PubMed  Google Scholar 

  8. 8.

    Revill, P. et al. Global strategies are required to cure and eliminate HBV infection. Nat. Rev. Gastroenterol. Hepatol. 13, 239–248 (2016).

    Article  PubMed  CAS  Google Scholar 

  9. 9.

    Nayagam, S. et al. Requirements for global elimination of hepatitis B: a modelling study. Lancet. Infect. Dis. 16, 1399–1408 (2016).

    Article  PubMed  Google Scholar 

  10. 10.

    Sugarman, J. et al. Ethics and hepatitis B cure research. Gut 66, 389–392 (2017).

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

The authors thank J. Pericàs and H. Nde for their input into an earlier draft of this article.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Jeffrey V. Lazarus.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Related links

WHO/UNICEF birth-dose vaccination coverage estimates: http://apps.who.int/immunization_monitoring/globalsummary/timeseries/tswucoveragebcg.html

Supplementary information

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Lazarus, J.V., Block, T., Bréchot, C. et al. The hepatitis B epidemic and the urgent need for cure preparedness. Nat Rev Gastroenterol Hepatol 15, 517–518 (2018). https://doi.org/10.1038/s41575-018-0041-6

Download citation

Further reading